Introduction
Aggregated data such as health insurance claims data become more and more available for research purposes. Recently, we proposed a new method to estimate the excess mortality in chronic diseases from aggregated age-specific prevalence and incidence data [Toe18, Bri19] .
So far, estimates of excess mortality have only been possible for ages 50+ and have shown to be unstable in younger ages. For example, in the simulation study of [Bri19] , the bias increases as the age decreases (Table 1 in [Bri19] ).
The aim of this article is to explore the reasons why estimates of excess mortality for younger ages are prone to bias and what can be done to extend the age range to ages below 50 years.
As a testing example, we use claims data about diabetes from the German statutory health insurance based on about 70 million people collected during the period from 2009 to 2015 [Gof17] .
Methods
It can be shown that the temporal change, ∂p = (∂ t +∂ a ) p of the age-specific prevalence p is related to the incidence rate i, the mortality rates m 0 and m 1 of the people with and without the disease, respectively, the general mortality m and the mortality rate ratio R = m 1 /m 0 via the following equations [Bri14, Bri16] :
Given the age-specific prevalence p, the age-specific incidence rate i and the general mortality rate m, Equations (1a) and (1b) can be used to estimate the excess mortality rate ∆m = m 1 -m 0 and the mortality rate ratio R:
Goffrier and colleagues report the age-specific prevalence p of type 2 diabetes for men in 2009 and 2015 [Gof17] . Furthermore, the age-and sex-specific incidence rate i in middle of the period, i.e., in the year 2012, is reported .These data are used as input for Equations (2a) and (2b). In addition, for applying Equation (2b) we use the general mortality m in 2012 from the Federal Statistical Office of Germany [Fed19] .
To obtain estimates for the excess mortality ∆m and the mortality rate ratio R, we essentially follow two directions: First, we apply Equations (2a) and (2b) directly to the input data (direct approach). In a second -indirect -approach, we choose candidate values for the mortality rate ratio R, solve Equation (1b) and compare the computed solution for the candidate R with the observed solution in terms of the squared differences. Both methods, direct and indirect are detailed in the next paragraphs.
Direct methods
The age-specific prevalence p for men in 2009 and 2015 are modeled by a linear regression model after application of a logit transformation. The age-specific incidence rate i for 2012 is modeled by a linear regression model after a log-transformation. In the direct estimation approach, we then seek to apply Equations (2a) and (2b). However, possible sampling uncertainties in the input data may lead to uncertainties in the estimated excess mortality rates ∆m and the mortality rate ratio R. To take these sampling uncertainties into account, the input For numerically solving the PDE (1b), the PDE is first converted into an ordinary differential equation (ODE) by the method of characteristics [Pol] and then, the associated ODE is solved by the Runge-Kutta Method of fourth order [Dah74] .
The rationale behind the indirect approach is the observation that direct application of (2a) and (2b) may lead to numerically instable results. Indications for a possible numerical instability may be seen in the ill-posedness of the inverse problem [Bri18] . Thus, the amount of uncertainty increases as the age decreases. Application of Equation (2b) for obtaining the mortality rate ratio R, yields the results as shown in Table 1 . We see that for ages below 55 years of age, the mortality rate ratios are implausibly high or even turn negative. By definition of the mortality rate ratio, a quotient of two positive rates, negative values are not possible. Thus, we see that direct estimates based on Equation (2b) do not yield sensible results for lower age groups and are not reliable. 
Results

Direct methods
Conclusion
In this manuscript we have described methods to estimate two epidemiological indices for the excess mortality of a chronic condition from age-specific prevalence and incidence data. From the current findings, we would recommend to estimate figures of the excess mortality on the mortality rate difference ∆m instead of the mortality rate ratio R. In the example application, estimates for the rate difference ∆m yield sensible results.
